Skip to main content

Advertisement

SpringerLink
Log in

Factors influencing platelet transfusion refractoriness in patients undergoing allogeneic hematopoietic stem cell transplantation

  • Original Article
  • Published:
Annals of Hematology Aims and scope Submit manuscript

Abstract

Hematopoietic stem cell transplantation has been considered a risk factor for development of platelet transfusion refractoriness. The objective of this study was to assess the platelet transfusion refractoriness rate in patients undergoing allogeneic hematopoietic stem cell transplantation from different sources. We retrospectively reviewed the charts and transfusion records of patients who underwent allogeneic stem cell transplantation at our institution between 2013 and 2015. The evaluation of post-transfusion platelet count was assessed for each transfusion given, from day of progenitor infusion to day 30 after transplantation. Of 167 patients included in this study, 101 received peripheral blood stem cell transplantation (PBSCT) and 66 received umbilical cord blood transplantation (UCBT). Overall, the percentage of platelet transfusions with a 14-h CCI lower than 5000 was 59.3%, being these data significantly higher for UCBT (67.6%) than for PBSCT (31.0%). Seventy-eight percent of patients underwent UCBT become refractory, while 38.6% of patients who received PBSCT were refractory. Factors associated to platelet refractoriness were lower CD34+ cell dose infused, higher number of antibiotics used, presence of anti-HLA I antibodies, and reduced-intensity conditioning regimen. Platelet refractoriness is a frequent and complex adverse event and remains a therapeutic challenge in the management of patients undergoing HSCT. There is a higher rate of platelet refractoriness in patients who received UCBT as compared to patients who received PBSCT.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Estcourt L, Stanworth S, Doree C, Hopewell S, Murphy MF, Tinmouth A et al (2012) Prophylactic platelet transfusion for prevention of bleeding in patients with haematological disorders alter chemotherapy and stem cell transplantation. Cochrane Database Syst Rev 5:CD004269

    Google Scholar 

  2. Annen K, Olson JE (2015) Optimizing platelet transfusions. Curr Opin Hematol 22:559–564

    Article  CAS  PubMed  Google Scholar 

  3. Solh M, Brunstein C, Morgan S, Weisdorf D (2011) Platelet and red blood cell utilization and transfusion independence in umbilical cord blood and allogeneic peripheral blood hematopoietic cell transplants. Biol Blood Marrow Transplant 17:710–716

    Article  PubMed  Google Scholar 

  4. Rebulla P (2005) A mini-review on platelet refractoriness. Haematologica 90:247–253

    PubMed  Google Scholar 

  5. Hod E, Schwartz J (2008) Platelet transfusion refractoriness. Br J Haematol 142:348–360

    Article  PubMed  Google Scholar 

  6. Stanworth SJ, Navarrete C, Estcourt L, Marsh J (2015) Platelet refractoriness-practical approaches and ongoing dilemmas in patient management. Br J Haematol 171:297–305

    Article  PubMed  Google Scholar 

  7. Forest SK, Hod EA (2016) Management of the platelet refractory patient. Hematol Oncol Clin N Am 30:665–677

    Article  Google Scholar 

  8. Balduini CL, Salvaneschi L, Klersy C, Noris P, Mazzucco M, Rizzuto F et al (2001) Factors influencing post-transfusional platelet increment in pediatric patients given hematopoietic stem cell transplantation. Leukemia 15:1885–1891

    Article  CAS  PubMed  Google Scholar 

  9. Ishida A, Handa M, Wakui M, Okamoto S, Kamakura M, Ikeda Y (1998) Clinical factors influencing posttransfusion platelet increment in patients undergoing hematopoietic progenitor cell transplantation-a prospective análisis. Transfusion 38:839–847

    Article  CAS  PubMed  Google Scholar 

  10. Sanz J, Arango M, Carpio N, Montesinos P, Moscardo F, Martin G et al (2014) Autoimmune cytopenias after umbilical cord blood transplantation in adults with haematological malignancies: a single-center experience. Bone Marrow Transplant 49(8):1084–1088

    Article  CAS  PubMed  Google Scholar 

  11. de La Serna J, Sanz J, Bermudez A, Cabrero M, Serrano D, Vallejo C et al (2016) Toxicity and efficacy of busulfan and fludarabine myeloablative conditioning for HLA-identical sibling allogeneic hematopoietic cell transplantation in AML and MDS. Bone Marrow Transplant 51:961–966

    Article  Google Scholar 

  12. Balaguer A, Bataller L, Lorenzo I, Jarque I, Salavert M, Gonzalez E et al (2017) Infections of the central nervous system following unrelated donor umbilical cord blood transplantation or HLA-matched sibling transplantation. Biol Blood Marrow Transplant 23(1):134–139

    Article  Google Scholar 

  13. Sanz J, Cano I, Gonzalez-Barbera EM, Arango M, Reyes J, Montesinos P et al (2015) Blood stream infections in adult patients undergoing cord blood transplantation from unrelated donors after myeloablative conditioning regimen. Biol Blood Marrow Transplant 21(4):755–760

    Article  PubMed  Google Scholar 

  14. Colhn C (2015) Transfusion support issues in hematopoietic stem cell transplantation. Cancer Control 22:52–59

    Article  Google Scholar 

  15. Bishop JF, Matthews JP, Yuen K, Wolf MM, Szer J (1991) Factors influencing 20-hour increments after platelet transfusion. Transfusion 31:392–396

    Article  CAS  PubMed  Google Scholar 

  16. Klumpp TR, Herman JH, Innis S, Pearlman E, Culling N, Kotz KW et al (1996) Factors associated with response to platelet transfusion following hematopoietic stem cell transplantation. Bone Marrow Transplant 17:1035–1041

    CAS  PubMed  Google Scholar 

  17. Toor AA, Choo SY, Little J (2000) Bleeding risk and platelet transfusion refractoriness in patients with acute myelogenous leukemia who undergo autologous stem cell transplantation. Bone Marrow Transplant 26:315–320

    Article  CAS  PubMed  Google Scholar 

  18. Guining L, Liu F, Mao X, Xu L (2011) The investigation of platelet transfusion refractory in 69 malignant patients undergoing hematopoietic stem cell transplantation. Transfus Apher Sci 45:21–24

    Article  Google Scholar 

  19. Zhang X, Xiao Y, Ran Q, Liu Y, Duan Q, Duan H et al (2012) Clinical observation of factors in the efficacy of blood component transfusion in patients following hematopoietic stem cell transplantation. PLoS One 7:e36912

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Barker JN, Kurtzberg J, Ballen K, Boo M, Brunstein C, Cutler C et al (2017) Optimal practices in unrelated donor cord blood transplantation for hematologic malignancies. Biol Blood Marrow Transplant 23:882–896

    Article  PubMed  Google Scholar 

  21. Sanz J, Wagner JE, Sanz MA, deFor T, Montesinos P, Bachanova V et al (2013) Myeloabaltive cord blood transplantation in adults with acute leukemia: comparison of two different transplant platforms. Biol Blood Marrow Transplant 19:1725–1730

    Article  PubMed  PubMed Central  Google Scholar 

  22. Lucchini G, Perales MA, Veys P (2015) Immune reconstitution after cord blood transplantation: peculiarities, clinical implications and management strategies. Cytotherapy 17:711–722

    Article  CAS  PubMed  Google Scholar 

  23. Le Viellez A, P’Ng S, Buffery S, Wright M, Cooney J, Cannell P et al (2015) Red cell and platelet transfusion burden following myeloablative allogeneic haematopoietic stem cell transplantation. Inter Med J 45:1286–1292

    Article  Google Scholar 

  24. Slichter SJ, Davis K, Enright H, Braine H, Gernsheimer T, Kao KJ et al (2005) Factors affecting post transfusion platelet increments, platelet refractoriness, and platelet transfusion intervals in thrombocytopenic patients. Blood 105:4106–4114

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Bock M, Muggenthaler KH, Schmidt U, Heim MU (1996) Influence of antibiotics on posttransfusion platelet increment. Transfusion 36:952–954

    Article  CAS  PubMed  Google Scholar 

  26. Stolla M, Refaai MA, Heal JM, Spinelli SL, Garraud O, Phipps RP et al (2015) Platelet transfusion: the new immunology of an old therapy. Front Immunol 6:28

    Article  PubMed  PubMed Central  Google Scholar 

  27. Hanson SR, Slichter SJ (1985) Platelet kinetics in patients with bone marrow hypoplasia: evidence for a fixed platelet requirement. Blood 66:1105–1109

    CAS  PubMed  Google Scholar 

  28. Bearman SI, Appelbaum FR, Buckner CD, Petersen FB, Fisher LD, Clift RA et al (1988) Regimen-related toxicity in patients undergoing bone marrow transplantation. J Clin Oncol 6:1562–1568

    Article  CAS  PubMed  Google Scholar 

  29. Juric MK, Ghimire S, Ogonek EM, Holler E, van Rood JJ, Oudshoorn M et al (2016) Milestones of hematopoietic stem cell transplantation—from first human studies to current developments. Front Immunol 7:470

    Article  PubMed  PubMed Central  Google Scholar 

  30. Bacigalupo A, Ballen K, Rizzo D, Giralt S, Lazarus H, ho V et al (2009) Defining the intensity of conditioning regimen; working definitions. Biol Blood Marrow Transplant 15:1628–1633

    Article  PubMed  PubMed Central  Google Scholar 

  31. The Trial to reduce alloimmunization to platelets study group (1997) Leucocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions. N Engl J Med 337:1861–1869

    Article  Google Scholar 

  32. Rioux-Massé B, Cohn C, Lindgren B, Pulkrabek S, McCullough J (2014) Utilization of cross matched or HLA-matched platelets for patients refractory to platelet transfusion. Transfusion 54:3080–3087

    Article  PubMed  Google Scholar 

  33. Beligaswatte A, Tsiopelas E, Humphreys I, Bennett G, Robinson K, Davis K et al (2013) The mean fluorescence intensities of anti-HLA antibodies detected using micro-bead flow cytometry predict the risk of platelet transfusion refractoriness. Br J Haematol 162:409–412

    Article  CAS  PubMed  Google Scholar 

  34. Christou G, Kekre N, Petrcich W, Tokessy M, Neurath D, Giulivi A et al (2015) Impact of platelet transfusion on toxicity and mortality after hematopoietic stem cell transplantation. Transfusion 55:253–258

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

Authors want to thank Mr. Paul E. Gutteridge for his assistance in the English revision of the manuscript.

Funding

This work was partially financed with FEDER funds (CIBERONC (CB16/12/00284)).

Author information

Authors and Affiliations

  1. Blood Bank, Hospital Universitari I Politècnic La Fe, Avda Abril Martorell, 46026, Valencia, Spain

    Pilar Solves, Jaime Sanz, Carmen Freiria, Marta Santiago, Ana Villalba, Inés Gómez, Pau Montesinos, Juan Montoro, Jose Luis Piñana, José Ignacio Lorenzo, Nieves Puig, Guillermo F Sanz, Miguel Ángel Sanz & Nelly Carpio

Authors
  1. Pilar Solves
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jaime Sanz
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Carmen Freiria
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Marta Santiago
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ana Villalba
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Inés Gómez
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Pau Montesinos
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Juan Montoro
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Jose Luis Piñana
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. José Ignacio Lorenzo
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Nieves Puig
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Guillermo F Sanz
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Miguel Ángel Sanz
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Nelly Carpio
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Pilar Solves.

Ethics declarations

Conflict of interest

Authors declare no conflict of interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Solves, P., Sanz, J., Freiria, C. et al. Factors influencing platelet transfusion refractoriness in patients undergoing allogeneic hematopoietic stem cell transplantation. Ann Hematol 97, 161–167 (2018). https://doi.org/10.1007/s00277-017-3168-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-017-3168-6

Keywords

Search

Navigation